Showing 7,721 - 7,740 results of 61,004 for search '(( a ((((laser decrease) OR (mean decrease))) OR (linear decrease)) ) OR ( a large decrease ))', query time: 1.12s Refine Results
  1. 7721

    JAK-STAT6 inhibitors decrease IL-13-induced eotaxin-3 expression in esophageal fibroblasts. by Edaire Cheng (297727)

    Published 2016
    “…<p>IL-13-induced (a) STAT6 phosphorylation, (b) eotaxin-3 mRNA, and (c) eotaxin-3 protein expression are decreased in esophageal fibroblasts, following treatment with JAK-STAT6 inhibitors (AS1517499 and leflunomide). …”
  2. 7722
  3. 7723
  4. 7724
  5. 7725
  6. 7726
  7. 7727
  8. 7728
  9. 7729

    Supplementary Material for: Enhanced Recovery after Surgery for Radical Cystectomy Decreases Postoperative Complications at Different Times by Lannes F. (11465377)

    Published 2021
    “…<b><i>Results:</i></b> A total of 150 patients underwent radical cystectomy, 74 without ERAS and 76 with ERAS protocol. …”
  10. 7730
  11. 7731
  12. 7732
  13. 7733
  14. 7734
  15. 7735
  16. 7736
  17. 7737
  18. 7738

    De-identified dataset. by Zeshan A. Chisty (18388200)

    Published 2024
    “…After an observed augmented effect with each spike exposure, a decline in the immune response, including %S IgG MBCs, was observed over time; the percent decline decreased with increasing spike exposures. …”
  19. 7739

    DataSheet_2_A cyclic peptide-based PROTAC induces intracellular degradation of palmitoyltransferase and potently decreases PD-L1 expression in human cervical cancer cells.docx by Yu-Ying Shi (15975992)

    Published 2023
    “…Introduction<p>Our previous research has found that degradation of palmitoyltransferase in tumor cells using a linear peptide PROTAC leads to a significant decrease in PD-L1 expression in tumors. …”
  20. 7740

    DataSheet_1_A cyclic peptide-based PROTAC induces intracellular degradation of palmitoyltransferase and potently decreases PD-L1 expression in human cervical cancer cells.docx by Yu-Ying Shi (15975992)

    Published 2023
    “…Introduction<p>Our previous research has found that degradation of palmitoyltransferase in tumor cells using a linear peptide PROTAC leads to a significant decrease in PD-L1 expression in tumors. …”